SRXH
Income statement / Annual
Last year (2025), SRx Health Solutions Inc.'s total revenue was $6.53 M,
a decrease of 81.32% from the previous year.
In 2025, SRx Health Solutions Inc.'s net income was -$45.01 M.
See SRx Health Solutions Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
09/30/2025 |
12/31/2024 |
09/29/2023 |
09/29/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$6.53 M |
$34.98 M |
$118.94 M |
$92.63 M |
$46.01 M |
$42.59 M |
| Cost of Revenue |
$5.04 M
|
$22.12 M
|
$95.33 M
|
$79.33 M
|
$32.30 M
|
$28.24 M
|
| Gross Profit |
$1.50 M
|
$12.86 M
|
$23.61 M
|
$13.31 M
|
$13.70 M
|
$14.35 M
|
| Gross Profit Ratio |
0.23
|
0.37
|
0.2
|
0.14
|
0.3
|
0.34
|
| Research and Development Expenses |
$0.00
|
$100.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$26.55 M
|
$13.14 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$2.95 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.93 M
|
$18.73 M
|
$29.49 M
|
$13.14 M
|
$30.98 M
|
$41.67 M
|
| Other Expenses |
$93.00 K
|
$0.00
|
-$75.10 K
|
$1.33 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.03 M
|
$18.83 M
|
$29.42 M
|
$14.47 M
|
$30.98 M
|
$41.67 M
|
| Cost And Expenses |
$18.06 M
|
$40.94 M
|
$124.75 M
|
$93.80 M
|
$63.29 M
|
$69.91 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$628.00 K
|
$467.00 K
|
$2.05 M
|
$753.71 K
|
$3.22 M
|
$9.25 M
|
| Depreciation & Amortization |
$31.00 K
|
$130.00 K
|
$1.70 M
|
$627.01 K
|
$1.66 M
|
$1.75 M
|
| EBITDA |
-$7.98 M |
$438.00 K |
-$7.05 M |
-$539.40 K |
$8.31 M |
-$48.34 M |
| EBITDA Ratio |
-1.22
|
0.01
|
-0.06
|
-0.01
|
0.18
|
-1.14
|
| Operating Income Ratio |
-1.76
|
-0.17
|
-0.05
|
-0.01
|
-0.38
|
-0.64
|
| Total Other Income/Expenses Net |
$2.89 M
|
$5.81 M
|
-$5.13 M
|
-$842.77 K
|
$20.70 M
|
-$32.01 M
|
| Income Before Tax |
-$8.64 M
|
-$159.00 K
|
-$10.94 M
|
-$2.01 M
|
$3.42 M
|
-$59.34 M
|
| Income Before Tax Ratio |
-1.32
|
-0
|
-0.09
|
-0.02
|
0.07
|
-1.39
|
| Income Tax Expense |
$0.00
|
$9.00 K
|
$196.58 K
|
$440.21 K
|
$37.00 K
|
$0.00
|
| Net Income |
-$45.01 M
|
-$168.00 K
|
-$11.14 M
|
-$2.45 M
|
$2.99 M
|
-$59.34 M
|
| Net Income Ratio |
-6.89
|
-0
|
-0.09
|
-0.03
|
0.06
|
-1.39
|
| EPS |
-2.13 |
-0.1 |
-0.9 |
-3.48 |
6.59 |
-319.69 |
| EPS Diluted |
-2.13 |
-0.1 |
-0.9 |
-3.48 |
6 |
-319.69 |
| Weighted Average Shares Out |
$21.11 M
|
$1.62 M
|
$12.39 M
|
$704.18 K
|
$452.91 K
|
$185.93 K
|
| Weighted Average Shares Out Diluted |
$21.11 M
|
$1.62 M
|
$12.39 M
|
$704.18 K
|
$497.79 K
|
$185.93 K
|
| Link |
|
|
|
|
|
|
